Loading...
PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9
PURPOSE OF REVIEW: Review novel insights into the biology of proprotein convertase subtilisin/kexin 9 (PCSK9) that may explain the extreme efficiency of PCSK9 inhibition and the unexpected metabolic effects resulting from PCSK9 monoclonal antibody therapy, and may identify additional patients as tar...
Na minha lista:
| Udgivet i: | Curr Opin Endocrinol Diabetes Obes |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4384821/ https://ncbi.nlm.nih.gov/pubmed/25692926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0000000000000137 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|